FDA Inspection
Lonza Biologics PlcLonza Biologics Plc – FDA Inspection, Sep 28, 2018
Record Details
This FDA Inspection record concerns Lonza Biologics Plc, with an inspection on September 28, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- Person
- Scott R. Nichols (Issuing Officer)
View Company Profile
ID · 1bbabf2a-b092-4b45-8b6d-7f670d3b114e
Inspection Facts
- Inspection number
- 1070651
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Lonza Biologics Plc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 13, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 5, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 31, 2017 | Not classified | Office of Inspections and Investigations | |
| June 24, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 24, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lonza Biologics Plc
- FDA Inspection 1202907 - 2022-10-13
- FDA Inspection 1097017 - 2018-09-05
- FDA Inspection 1021064 - 2017-03-31
- FDA Inspection 978909 - 2016-06-24
- FDA Inspection 801062 - 2012-09-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.